Clinical outcome of patients with early stage breast cancer treated with accelerated partial breast irradiation using stereotactic body radiotherapy with Cyberknife – the CK-APBI cohort

CK-APBI Cohort

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON23192

Enrollment

200

Registered

2019-07-12

Start date

2019-08-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: • Female • Intention to treat with CK-APBI at Erasmus MC • Written informed consent

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
toxicity, scored according to the CTCAE v5.0 (dermatitis, breast pain and fibrosis).	—

Secondary

Measure	Time frame
cosmetic results, rated by the patient and physician, and recurrence rates	—

Contacts

Public ContactNienke Hoekstra

Erasmus MC

n.hoekstra@erasmusmc.nl0107040704

Outcome results